Literature DB >> 3716218

Three cone mechanisms in the primate electroretinogram: two with, one without off-center bipolar responses.

H U Evers, P Gouras.   

Abstract

We have used ganzfeld stimulation, selective chromatic adaptation and computer averaging to identify three cone mechanisms in the corneal ERG of the macaque monkey. On a strong yellow background, two cone mechanisms can be distinguished. One has a peak spectral sensitivity near 460 nm with a relatively slow b-wave to light onset and a negative wave at offset. This response is transiently reduced after a yellow background is extinguished. The second has its peak near 560 nm with a quicker b-wave at onset and a positive wave (d-wave) at offset. On a strong blue background, the ERG appears univariant from 400 to 600 nm but not at longer wavelengths (640 nm). An even brighter blue background reduces the ERG to most of the spectrum but has almost no affect on the 640 nm response. Adding an additional red background greatly reduces the 640 nm response without significantly influencing the responses to the rest of the spectrum. By Granit's terminology, the cone ERG appears to be composed of an E-like ERG of short wave cones and an I-like ERG of at least two other cone mechanisms. The difference between E and I ERGs may be due to the absence or presence, respectively, of an off-center bipolar system. The intravitreal injection of 2-amino-4-phosphonobutyric acid (APB) supports this hypothesis. APB eliminates the b-wave of all three cone ERGs and the negative off-response of the S cone ERG but releases the positive off-response of the other cone ERGs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3716218     DOI: 10.1016/0042-6989(86)90019-2

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  24 in total

1.  A new component in the a-wave of the human cone electroretinogram.

Authors:  P Gouras; C MacKay
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  Assessment of local cone on- and off-pathway function using multifocal ERG technique.

Authors:  M Kondo; Y Miyake
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  The ERG of guinea pig (Cavis porcellus): comparison with I-type monkey and E-type rat.

Authors:  Bo Lei
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

4.  Electroretinographic evaluation of the retinal S-cone system.

Authors:  Maja Sustar; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2011-11-27       Impact factor: 2.379

5.  On- and off-response ERGs elicited by sawtooth stimuli in normal subjects and glaucoma patients.

Authors:  Gobinda Pangeni; Robert Lämmer; Ralf P Tornow; Folkert K Horn; Jan Kremers
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

6.  The human focal electroretinogram as a function of stimulus area.

Authors:  P Errico; B Falsini; V Porciatti; F M Cefalá
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

7.  ON- and OFF-response of the photopic electroretinogram in relation to stimulus characteristics.

Authors:  Maja Sustar; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2006-08-12       Impact factor: 2.379

8.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

9.  Effects of Spectral Characteristics of Ganzfeld Stimuli on the Photopic Negative Response (PhNR) of the ERG.

Authors:  Nalini V Rangaswamy; Suguru Shirato; Muneyoshi Kaneko; Beth I Digby; John G Robson; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

Review 10.  The role of S-cones in human vision.

Authors:  Peter Gouras
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.